Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Operating activities:
Net loss	$ (208,160)	$ (190,426)	$ (434,801)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	41,764	30,968	24,097
Amortization of acquired intangible assets	1,720
Expensed in-process research and development			2,679
Non-cash lease expense	20,198	15,325	14,519
Stock-based compensation	354,404	274,428	191,808
Amortization of premiums and accretion of purchase discounts on investment securities	32	(618)	1,087
Change in fair value of warrants and preferred stock of related party equity investment	(3,235)
Foreign exchange adjustment	17	462	265
Amortization of debt discount and issuance cost		991	1,292
Non-cash interest expense	(39)	2,835	52
Non-cash expense recovery	(1,445)	(442)
Changes in operating assets and liabilities:
Accounts receivable	20,752	(35,876)	(33,904)
Inventory	(20,871)	(3,985)	(5,353)
Operating lease right-of-use assets	4,229		8,354
Prepaid expenses and other assets	(8,634)	10,807	(26,072)
Accounts payable	753	13,210	(15,458)
Accrued compensation	60,269	40,328	21,619
Deferred tax liability	(60,800)
Operating lease liabilities	(19,751)	(16,819)	(12,448)
Other accrued liabilities	31,345	(6,376)	10,347
Deferred revenue	2,753	852	4,962
Net cash provided by (used in) operating activities	215,301	135,664	(246,955)
Investing activities:
Purchases of investments		(122,010)	(98,303)
Proceeds from sale of investments		24,822
Proceeds from maturity of investments	23,000	314,400	306,000
Purchases of property and equipment, net	(106,188)	(66,423)	(39,199)
Purchase of intangible assets, net	(33,000)	(10,495)
Investment in related party		(2,670)
Cash paid for business combination, net	(16,021)
Net cash (used in) provided by investing activities	(132,209)	137,624	168,498
Financing activities:
Proceeds from exercise of stock options	22,536	12,988	3,892
Proceeds from issuance of common stock under employee stock purchase plan	25,037	17,298	15,128
Proceeds from public offering, net of issuance cost			235,441
Stock issuance costs	(112)
Cash redemption on Convertible Note		(82)
Net cash provided by financing activities	47,461	30,204	254,461
Net change in cash, cash equivalents and restricted cash	130,553	303,492	176,004
Beginning cash, cash equivalents and restricted cash	945,587	642,095	466,091
Ending cash, cash equivalents and restricted cash	1,076,140	945,587	642,095
Supplemental disclosure of cash flow information:
Cash paid for income taxes, net	499	1,307	295
Cash paid for interest	4,069	7,897	11,346
Non-cash activities:
Purchases of property and equipment in accounts payable and accruals	(1,014)	9,374	1,582
Acquisition of warrants		9,424
Amounts accrued for acquisition of intangible assets	3,000	1,400
Contingent consideration for business combination	118,360
Issuance of common stock for business combination	287,428
Issuance of common stock for IPR&D milestone			14,435
Issuance of common stock for bonuses	32,875	24,071	19,774
Stock-based compensation included in capitalized software development costs	$ 2,899	2,263	$ 629
Debt and interest converted into equity		$ 286,730